<?xml version="1.0" encoding="UTF-8"?>
<p>Clinical evidence. 
 <italic>Pimpinella anisum</italic> preparations have been trialed clinically for asthma. The bronchodilator activity of 
 <italic>P. anisum</italic> was evaluated in a study involving 50 patients presenting bronchial asthma. The patients ingested tea (2 g in 200 ml of water), twice a day for 40 days. All patients presented a reduction of cough episodes after 21 days of treatment (from more than 6 episodes/day to none), as well as dyspnea and wheezing. Also, an improvement in the breath-holding time and respiratory rate was observed (
 <xref rid="B373" ref-type="bibr">Paheerathan, 2019</xref>). Overall, the clinical evidence is High for asthma-related cough and Low for cough and fever.
</p>
